# Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)

> **NCT01840319** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 156 (actual)

## Conditions studied

- Survival Status at Day 30 After the Last Intake

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01840319
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01840319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01840319, "Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01840319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*